Preliminary unaudited results for the full year ended 31 December 2024 Great end to a solid year, well placed for FY25 and beyond; announcing €1bn share buyback* over next 12 months UXBRIDGE, UNITED KINGDOM / ACCESS Newswire / February 14, 2025 / (NASDAQ:CCEP)(LSE:CCEP) FY 2024 Total CCEP Key Financial Metrics [1] As Reported Comparable [1] Change vs FY 2023 Adjusted Comparable [4] Change vs FY 2023 As Reported Comparable [1] Comparable FXN [1] Adjusted Comparable [4] Adjusted Comparable FXN [4] Volume (M UC) [2] 3,864 3,864 17.8 % 16.9% 3,965 0.0% Revenue per UC [2] (€) 5.30 (5.1)% 5.23 2.7% …

Allocation of shares to certain primary insiders and their close associates in Equinor (OSE: EQNR, NYSE: EQNR) under Equinor's share savings plan.

Global oil demand hits 103.4M BPD as natural gas stays bullish above $3.720. Key levels suggest potential market shifts ahead.

Reddit shares dropped 15% post-earnings despite strong results, presenting a potential buying opportunity for long-term investors. Q4 2024 saw revenues of $428 million, a 71% increase, crushing street estimates yet again, while reporting strong bottom-line improvement. Current quarter guidance was above expectations, and RDDT's improving financials suggest the potential for S&P 500 inclusion.

SAN DIEGO , Feb. 14, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025. Merck is a global healthcare company.

Qualcomm's recent earnings report shows strong growth, despite some market pessimism, highlighting the company's potential in portable AI and edge computing. Portable AI, driven by models like DeepSeek, positions QCOM to benefit from increased demand for AI chips in smartphones and IoT devices. The Company's valuation is attractive, with a forward P/E ratio significantly below the sector median, suggesting a potential upside of around 25.88%.

Nu Skin Enterprises, Inc. (NYSE:NUS ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants B.G. Hunt - Head of Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Sydney Wagner - Jefferies Christina Xue - D.A.

MILWAUKEE--(BUSINESS WIRE)--Ademi & Fruchter LLP is investigating Intevac (Nasdaq: IVAC) for possible breaches of fiduciary duty and other violations of law in its transaction with Seagate. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the tender offer transaction, Intevac stockholders will receive only $4.00 per share, with an additional $.102 per.

LightPath Technologies, Inc. (NASDAQ:LPTH ) Q2 2025 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Sam Rubin - President and Chief Executive Officer Albert Miranda - Chief Financial Officer Conference Call Participants Jaeson Schmidt - Lake Street Capital Markets Glenn Mattson - Ladenburg Thalmann & Co. Inc. Orin Hirschman - AIGH Investment Partners Scott Buck - H.C. Wainwright & Co. Brian Kinstlinger - Alliance Global Partners Richard Shannon - Craig Hallum Capital Group Operator Good afternoon, ladies and gentlemen.

RADNOR, Pa. , Feb. 14, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Integral Ad Science Holding Corp. ("IAS") (NASDAQ: IAS) on behalf of those who purchased or otherwise acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the "Class Period").

Crocs has regained brand recognition in the past few years, and the Q4 report highlights continued great revenues and incredibly high margins. The HEYDUDE brand is still waiting for stabilization. Zooming out, CROX's history has been turbulent. The constant celebrity and brand collaborations highlight a currently hot brand, but fashion trends may change—the Company's earnings have asymmetric downside. At a single-digit P/E, the stock already prices in a stagnating brand. I estimate 9% upside to a fair value of $116 in a DCF model base scenario.

Procore Technologies, Inc. (NYSE:PCOR ) Q4 2024 Results Earnings Conference Call February 14, 2025 5:00 PM ET Company Participants Alexandra Geller - Head, Investor Relations Tooey Courtemanche - Founder, President and Chief Executive Officer Howard Fu - Chief Financial Officer Conference Call Participants Brent Bracelin - Piper Sandler Joe Vruwink - Robert W. Baird DJ Hynes - Canaccord Brent Thill - Jefferies Saket Kalia - Barclays Dylan Becker - William Blair Adam Borg - Stifel Daniel Jester - BMO Capital Markets Jason Celino - KeyBanc Capital Markets Alexei Gogolev - J.P.

Trinseo PLC (NYSE:TSE ) Q4 2024 Earnings Conference Call February 13, 2025 10:00 AM ET Company Participants Bee Van Kessel - Senior Vice President, Corporate Finance and Investor Relations Frank Bozich - President and Chief Executive Officer David Stasse - Executive Vice President and Chief Financial Officer Conference Call Participants Frank Mitsch - Fermium Research Matthew Blair - Tudor, Pickering Holt & Company Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Roger Spitz - Bank of America Alex Kelsey - Wells Fargo David Begleiter - Deutsche Bank Operator Good morning, ladies and gentlemen, and welcome to the Trinseo …

Palomar Holdings, Inc. (NASDAQ:PLMR ) Q4 2024 Earnings Call February 13, 2025 12:00 PM ET Company Participants Chris Uchida - Chief Financial Officer Mac Armstrong - Chairman and Chief Executive Officer Jon Christianson - President Conference Call Participants Paul Newsome - Piper Sandler Mark Hughes - Truist Securities Andrew Andersen - Jefferies Meyer Shields - KBW Pablo Singzon - JPMorgan Operator Good morning and welcome to the Palomar Holdings, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

GoDaddy, Inc. (NYSE:GDDY ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Christie Masoner - Vice President of Investor Relations Aman Bhutani - Chief Executive Officer Mark McCaffrey - Chief Financial Officer Conference Call Participants Vikram Kesavabhotla - Baird Ken Wong - Oppenheimer Josh Beck - Raymond James Aaron Kessler - Seaport Research Trevor Young - Barclays Robert Coolbrith - Evercore Ygal Arounian - Citi Elizabeth Elliott - Morgan Stanley Mark Zgutowicz - The Benchmark Company Naved Khan - B. Riley Securities Christie Masoner Welcome to GoDaddy's Fourth Quarter and Full Year 2024 Earnings Call.

RBI delivered strong Q4 results, beating sales and EPS, with same-store sales growing 2.3% year-over-year, thanks to Tim Hortons' dominance in Canada. Tim Hortons continues to excel with 15 consecutive quarters of positive traffic growth, contributing significantly to RBI's overall performance and revenue. Despite challenges, Burger King and Popeyes showed signs of recovery in Q4, with Burger King remodeling efforts boosting future prospects.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=129450&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=129451&wire=1 or contact Joseph E. Levi, Esq.

Nano-X Imaging is my speculative play for disruptive innovation in the biotech sector. With the S&P 500 at historical highs, lagging sectors like healthcare seem relatively attractive. The biotech sector's large market size and potential make it an intriguing investment opportunity. The AI push in health sector is a long-term tailwind. NNOX is positioned well in offering real value from the AI system.

Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Edward Chung - Vice President of Investor Relations Jon DiVincenzo - President & Chief Operating Officer Roop Lakkaraju - Executive Vice President & Chief Financial Officer Norman Schwartz - Chairman of the Board, President & Chief Executive Officer Conference Call Participants Dan Leonard - UBS Brandon Couillard - Wells Fargo Jack Meehan - Nephron Research Conor McNamara - RBC Capital Markets Tycho Peterson - Jefferies Operator Thank you for standing by. My name is Prila [ph] and I will be your conference …